There were 953 press releases posted in the last 24 hours and 442,562 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ViaDerma, Inc. Receives Positive Results on Phase I Testing in Canada with its Proprietary THC Delivery and Moves to Phase II Trials and development of New Products with its MMJ Technologies

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image